本文已被:浏览 1947次 下载 1618次 |
码上扫一扫! |
门静脉金属内支架结合经动脉化疗栓塞手术治疗肝癌门静脉癌栓 |
李文涛,董生,贾宁阳,欧阳强,严昺 |
|
(复旦大学肿瘤医院放射诊断科,上海,200032;第二军医大学长征医院影像科,上海,200433) |
|
摘要: |
目的:探讨门静脉金属内支架结合经动脉化疗栓塞术(TACE)治疗肝癌合并门静脉癌栓的临床效果.方法:11例盱癌门静脉癌栓患者采用肝穿刺途径置入门静脉金属内支架,同时(或1周后)行TACE.记录手术成功、狭窄开通、并发症和手术死亡发生情况,随访支架通畅期和患者生存期.结果:门静脉通路穿刺成功率11/11;门脉支架置入成功率10/11;发生肝性脑病及肝功能衰竭1例.支架中位通畅期5.7个月(1~18个月);治疗后3个月、6个月及1年患者生存率分别为5/11、4/11、2/11.结论:对巨块型肝癌合并门静脉癌栓、但无远处广泛转移的患者,采用支架开通门脉主干及远端为非肿瘤所在肝叶的门脉,结合TACE治疗,可取得较好的疗效. |
关键词: 肝肿瘤、门静脉癌栓、金属内支架、门静脉、经动脉化疗栓塞术 |
DOI:10.3724/SP.J.1008.2006.00771 |
投稿时间:2005-12-06修订日期:2006-06-01 |
基金项目: |
|
Portal vein stenting combined with transcatheter hepatic arterial chemoembolization in treatment of portal vein tumor thrombus in patients with primary hepatic carcinoma |
LI Wen-tao,DONG Sheng,JIA Ning-yang,OUYANG Qiang,YAN Bing |
(复旦大学肿瘤医院放射诊断科,上海,200032;第二军医大学长征医院影像科,上海,200433) |
Abstract: |
Objeetive:To discuss the clinical outcomes of portal vein stenting combined with transeatheter hepatic arterial ehemoembolization (TACE) in treating portal vein tumor thrombus in the patients with primary hepatic carcinoma (PHC). Methods: Eleven PHC patients with tumor thrombus in the main branch or trunk of the portal vein were treated with stenting and TACE simultaneously (or TACE were performed 1 week later). The successful rate of the procedure, the pateney of the obstruction, the complications, the mortality and the survival periods were all recorded. Results: Portal vein puncture was sueeessfully performed in all 11 eases and successful stenting was achieved in 10 eases. Hepatic eneephalopathy combined with hepatic failure was noticed in 1 patient. The median pateney period after stenting was 5.7 (1-18) months. The survival rates of patients at 3, 6 and 12 months after treatment were 5/ 11,4/ 11 and 2/ 11, respectively. Conelusion: Metallic stent implantation combined with TACE has satisfactory outcome in treating tumor thrombus in the main branch and trunk of the portal vein in PHC patients without distant metastases. |
Key words: liver neoplasms portal cancerous thrombus metallic stent portal vein transeatheter hepatic arterial ehemoembdization |